21 Jan 2021 --- Neuropathix (formerly known as Kannalife) has landed a patent for its hops-inspired synthesized neuroprotectant, NPTX-204. The pharmaceutical ingredient is based on phosphatidylcholines (PC) containing long-chain polyunsaturated fatty acids (PUFAs).
